Placebo Effect in Levodopa-Induced Dyskinesia: A Systematic Review and Meta-Analysis [0.03%]
左旋多巴引起的异动症的安慰剂效应：系统评价和荟萃分析
Luiz Vinicius Silva Correa,Alexandre Martins do Nascimento,Bruno Lopes Santos-Lobato et al.
Luiz Vinicius Silva Correa et al.
Background: Levodopa-induced dyskinesia (LID) is a complication of Parkinson's disease (PD) treatment. While the placebo effect is a known component in PD clinical trials, its specific magnitude in the context of LID is n...
Real-World Patterns of Botulinum Toxin Treatment in Hyperkinetic Movement Disorders: A 9-Year Nationwide Analysis in France [0.03%]
肉毒杆菌治疗肌张力障碍的现实模式——一项为期九年的全国性分析研究报告
Marion Simonetta-Moreau,Pierre Karam,Anne Forestier et al.
Marion Simonetta-Moreau et al.
Background: Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT-A). Real-world evidence on treatment patterns remains limite...
Hemi-Chorea in Anti-GQ1b Syndrome: Expanding the Movement Disorder Spectrum [0.03%]
抗GQ1b抗体综合征的半侧舞蹈症：运动障碍谱系的新发现
Ashutosh Gupta
Ashutosh Gupta
Re-Emergent Postural Tremor Without Clinical Resting Tremor in Parkinson's Disease-A Case Report [0.03%]
帕金森病姿势性震颤再发一例报告
Kevin R E van den Berg,Rick C Helmich
Kevin R E van den Berg
A Schizophrenia-Spectrum Presentation with Panda Sign: Huntington's Disease Confirmed, Wilson Disease Excluded [0.03%]
具有熊猫征的精神分裂症谱系表现：排除威尔森氏病确诊亨廷顿舞蹈病
Eva-Maria Tsapakis,Georgia Zafeiridou,Elizabeth Psoma et al.
Eva-Maria Tsapakis et al.
Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR-PSP) [0.03%]
印度进行性核上性麻痹的多中心临床队列研究（项目PAIR-PSP）见解
Prashanth Lingappa Kukkle,Divyani Garg,Jacky Ganguly et al.
Prashanth Lingappa Kukkle et al.
Background: Progressive supranuclear palsy (PSP) is a rare and devastating tauopathy with limited global data. Given India's large population, genetic diversity, and clinical heterogeneity, large multicenter datasets are ...
Hereditary Spastic Paraplegia Type 83 with Homozygous Variant in HPDL, Report of 3 Cases in a Mexican Family [0.03%]
一例墨西哥家族的遗传性痉挛性截瘫83型同型变异HPDL报告，3例
Andrea B Fiscal-Carvajal,Graciela A López-Uriarte,Laura E Martínez-Garza et al.
Andrea B Fiscal-Carvajal et al.
Substantia Nigra Neuromelanin Magnetic Resonance Imaging in LRRK2 Asymptomatic Carriers [0.03%]
无症状携带者LRRK2黑质 neuromelanin 磁共振成像
Vanessa Carvalho,Joana Freitas,Carla Guerreiro et al.
Vanessa Carvalho et al.
Background: Neuromelanin (NM)-sensitive MRI of the substantia nigra is a biomarker of neurodegeneration in Parkinson's disease (PD), which is expected to begin years before motor symptoms emerge, and for which LRRK2 mutat...
PREDICT-PD: A Two-Stage Approach to Early Identification of Parkinson's Disease [0.03%]
基于预测帕金森病的预测模型研究
Sasivimol Virameteekul,Sheena Waters,Brook Huxford et al.
Sasivimol Virameteekul et al.
Stress Management and Resiliency Training in People with Parkinson's Disease and their Care Partners [0.03%]
帕金森病患者与照料者中的压力管理和复原力训练
Carine W Maurer,Sandra Skinner,Vera N Kulikov et al.
Carine W Maurer et al.
Background: People with Parkinson's disease (PwP) and their care partners experience stress and mental health concerns that affect quality of life and illness management. Mind-body interventions may facilitate adaptive co...